Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Reporting to the VP of Financial Planning and Analysis, Vir Biotechnology is looking for a Sr. Director, FP&A to support Corporate FP&A and be the lead finance business partner to the Clinical Development & Technical Operations functions. You will serve as trusted financial advisor to our Chief Medical and Chief Technical Operations Officers and their leadership teams, providing critical financial forecasting, reporting, and insights in support of the company’s oncology and infectious disease development pipeline. The position requires strong excel, analytical, and cross functional collaboration skills, with a sound understanding of the biopharmaceutical development lifecycle.
This role is located in our San Francisco headquarters with an expectation of 3 days per week in office.
WHAT YOU'LL DO- Serve as a trusted finance business partner for our Executive Leaders; serve as the subject matter expert on cross-functional project teams, offering tailored guidance for protocol amendments, program changes, major spend commitments and upcoming inflection points
- Responsible for all aspects of Clinical Development & Technical Operations functions financials, including budget, forecast, long-range plan, early pipeline financials, scenario analysis, and ad hoc analysis
- Oversee the development of Clinical Development financial models for annual budget cycle, mid-year forecasts and long-range plan
- Develop, maintain, and enhance complex financial models for clinical trials and development programs, integrating enrollment projections, timelines, FTE estimates, and vendor spend.
- Drive the Functional financial planning calendar and ensure accountability across all functions for delivering results on-time
- Manage the consolidation of quarterly and annual financial reports related to Clinical Development & Technical Operations functions.
- Present financial data and results to members of senior leadership team and finance management
- Partner with Business Development to model financial impact of various deal types, including in-licensing, out-licensing, partnerships and acquisitions
- Support evaluation, design, implementation, and maintenance of financial systems and system upgrades
- Drive continuous process improvements in planning, modeling and reporting methodologies to support and evolving R&D pipeline
- Mentor peers and lead FP&A professionals focused on clinical/R&D finance, fostering a culture of excellence and continuous development.
- Support ad hoc analysis and projects across the organization
- Bachelor's degree or equivalent in accounting, finance, or related fields with 18+ years of experience in biotech finance related roles
- Deep experience and expertise of pharmaceutical drug development processes
- Excel power user, experience with Netsuite, Adaptive Insights, and Coupa a plus
- Excellent knowledge of US GAAP accounting and SOX requirements
- Track record of effectively partnering across the organization with a collaborative style working across internal and external teams
The expected Salary range for this position is $227,500 to $318,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Top Skills
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™. Join us as we pursue our mission to transform lives. It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
%20(1).png)
